Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits.
A leading role for NADPH oxidase in an in-vitro study of experimental autoimmune encephalomyelitis.
Bone mineral density levels in adults with multiple sclerosis: A meta-analysis.
Obesity interacts with infectious mononucleosis in risk of multiple sclerosis.
1,25-dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation.
The role of cannabinoids and leptin in neurological diseases.
There is no evidence to support or refute the effectiveness of memory rehabilitation on memory function or functional abilities in people with multiple sclerosis.
Risk of Demyelinating Diseases in the Central Nervous System in Patients With Inflammatory Bowel Disease Treated With Tumor Necrosis Factor Inhibitors.
Translation, Cultural Adaptation and Validation of the Qualiveen-30 Questionnaire in Persian for Patients with Spinal Cord Injury and Multiple Sclerosis.
Neuroimaging and genetic correlates of cognitive dysfunction in multiple sclerosis.
Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?
[Pathology of Charcot-Marie-Tooth Disease].
Non-Neuronal Cells Are Required to Mediate the Effects of Neuroinflammation: Results from a Neuron-Enriched Culture System.
Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England: Comparison of A Markov and Discrete Event Simulation Model.
Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration.
Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.
In vivo regulation of gene expression and Th17 differentiation by RORγt inverse agonists.
The diagnostic value of MRI in pediatric chronic inflammatory demyelinating polyradiculoneuropathy.
Masquerades of Acquired Demyelination in Children: Experiences of a National Demyelinating Disease Program.
[Pathology and definition of multiple sclerosis].
[The usefulness of 3T magnetic resonance in the differential diagnosis of ischemic optic neuropathy and inflammatory optic neuritis].
Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease.
The Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature.
The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
Body Mass Index in Multiple Sclerosis: Associations with CSF Neurotransmitter Metabolite Levels.
Pages
« first
‹ previous
…
675
676
677
678
679
680
681
682
683
…
next ›
last »